Expanded Safety Analysis of Pevonedistat, a First-in-class NEDD8-activating Enzyme Inhibitor, in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes
BLOOD CANCER JOURNAL（2017）
关键词
Acute myeloid leukaemia,Drug development,Biomedicine,general,Cancer Research,Oncology,Hematology
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要